Athanor Capital, LP Crispr Therapeutics Ag Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $224,097 - $425,120	-2,024 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $161,252 - $350,617	2,024 New	2,024 $310,000
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $215,561 - $276,357	-2,746 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $105,721 - $208,833	2,746 New	2,746 $202,000
Q1 2020 May 14, 2020	SELL	$33.68 - $62.53 $199,048 - $369,552	-5,910 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $216,778 - $432,198	5,910 New	5,910 $360,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.